Top-Rated StocksTop-RatedNASDAQ:SGRY Surgery Partners (SGRY) Stock Forecast, Price & News $30.03 +0.07 (+0.23%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$29.84▼$30.3750-Day Range$29.96▼$44.0652-Week Range$20.46▼$45.79Volume260,219 shsAverage Volume586,735 shsMarket Capitalization$3.80 billionP/E RatioN/ADividend YieldN/APrice Target$44.09 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Surgery Partners MarketRank™ ForecastAnalyst RatingModerate Buy2.89 Rating ScoreUpside/Downside46.8% Upside$44.09 Price TargetShort InterestBearish9.52% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.45Based on 4 Articles This WeekInsider TradingSelling Shares$230,425 Sold Last QuarterProj. Earnings Growth20.34%From $0.59 to $0.71 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.04 out of 5 starsMedical Sector556th out of 965 stocksGeneral Medical & Surgical Hospitals Industry5th out of 5 stocks 3.4 Analyst's Opinion Consensus RatingSurgery Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 8 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $44.09, Surgery Partners has a forecasted upside of 46.8% from its current price of $30.03.Amount of Analyst CoverageSurgery Partners has only been the subject of 3 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.52% of the float of Surgery Partners has been sold short.Short Interest Ratio / Days to CoverSurgery Partners has a short interest ratio ("days to cover") of 8.3.Change versus previous monthShort interest in Surgery Partners has recently increased by 6.72%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSurgery Partners does not currently pay a dividend.Dividend GrowthSurgery Partners does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SGRY. Previous Next 2.5 News and Social Media Coverage News SentimentSurgery Partners has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Surgery Partners this week, compared to 3 articles on an average week.Search Interest10 people have searched for SGRY on MarketBeat in the last 30 days. This is an increase of 900% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Surgery Partners to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Surgery Partners insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $230,425.00 in company stock.Percentage Held by InsidersOnly 2.60% of the stock of Surgery Partners is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Surgery Partners are expected to grow by 20.34% in the coming year, from $0.59 to $0.71 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Surgery Partners is -53.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Surgery Partners is -53.62, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSurgery Partners has a P/B Ratio of 1.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Surgery Partners (NASDAQ:SGRY) StockSurgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. The company was founded in 2004 and is headquartered in Brentwood, Tennessee.Read More SGRY Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SGRY Stock News HeadlinesSeptember 23, 2023 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Rating Increased to Hold at StockNews.comSeptember 21, 2023 | americanbankingnews.comSurgery Partners, Inc. (NASDAQ:SGRY) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesSeptember 24, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.September 17, 2023 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Stock Rating Reaffirmed by Cantor FitzgeraldSeptember 17, 2023 | americanbankingnews.comSurgery Partners (NASDAQ:SGRY) Lowered to Sell at StockNews.comSeptember 16, 2023 | msn.comSurgery Partners: Capital Intensity Without The Earnings (Rating Downgrade)September 15, 2023 | msn.comCantor Fitzgerald Reiterates Surgery Partners (SGRY) Overweight RecommendationSeptember 5, 2023 | finance.yahoo.comReturns At Surgery Partners (NASDAQ:SGRY) Are On The Way UpSeptember 24, 2023 | Chaikin Analytics (Ad)His system isolated NVIDIA - Here's His Next Buy.Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.August 17, 2023 | finance.yahoo.comDown -22.17% in 4 Weeks, Here's Why Surgery Partners (SGRY) Looks Ripe for a TurnaroundAugust 9, 2023 | finance.yahoo.comSurgery Partners (NASDAQ:SGRY) shareholders are still up 108% over 5 years despite pulling back 3.7% in the past weekAugust 9, 2023 | fool.comSurgery Partners (NASDAQ: SGRY)August 4, 2023 | markets.businessinsider.comMizuho Securities Keeps Their Buy Rating on Surgery Partners (SGRY)August 2, 2023 | msn.comBarclays Maintains Surgery Partners (SGRY) Overweight RecommendationAugust 2, 2023 | markets.businessinsider.comSurgery Partners (SGRY) Receives a Buy from BarclaysAugust 1, 2023 | finance.yahoo.comSurgery Partners, Inc. Announces Second Quarter 2023 ResultsAugust 1, 2023 | finance.yahoo.comSurgery Partners (SGRY) Surpasses Q2 Earnings EstimatesAugust 1, 2023 | finance.yahoo.comSurgery Partners Stock Getting Closer To Key Technical BenchmarkAugust 1, 2023 | finance.yahoo.comCompared to Estimates, Surgery Partners (SGRY) Q2 Earnings: A Look at Key MetricsJuly 19, 2023 | finance.yahoo.comSurgery Partners, Inc. Announces Second Quarter 2023 Earnings Release Date and Conference Call DetailsJuly 11, 2023 | msn.comMizuho Maintains Surgery Partners (SGRY) Buy RecommendationJune 24, 2023 | seekingalpha.comSurgery Partners: Great Catalysts, But A Bad PriceJune 24, 2023 | seekingalpha.comSurgery Partners: Exceptional Business Economics, Trading Below Fair ValueJune 17, 2023 | theglobeandmail.comSurgical Centers, Med-Tech Stocks Up On Pent-Up Surgical DemandJune 15, 2023 | finance.yahoo.comStrength Seen in Surgery Partners (SGRY): Can Its 5.0% Jump Turn into More Strength?June 6, 2023 | yahoo.comEndometriosis Recurrence After SurgeryJune 2, 2023 | msn.comB of A Securities Upgrades Surgery Partners (SGRY)See More Headlines Receive SGRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address SGRY Company Calendar Last Earnings8/01/2023Today9/24/2023Next Earnings (Estimated)11/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry General medical & surgical hospitals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SGRY CUSIPN/A CIK1638833 Webwww.surgerypartners.com Phone(615) 234-5900Fax615-234-5998Employees12,200Year FoundedN/APrice Target and Rating Average Stock Price Forecast$44.09 High Stock Price Forecast$51.00 Low Stock Price Forecast$35.00 Forecasted Upside/Downside+46.8%Consensus RatingModerate Buy Rating Score (0-4)2.89 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($0.56) Trailing P/E RatioN/A Forward P/E Ratio50.90 P/E GrowthN/ANet Income$-54,600,000.00 Net Margins-2.04% Pretax Margin3.61% Return on Equity1.95% Return on Assets0.81% Debt Debt-to-Equity Ratio0.84 Current Ratio1.77 Quick Ratio1.61 Sales & Book Value Annual Sales$2.54 billion Price / Sales1.50 Cash Flow$0.89 per share Price / Cash Flow33.89 Book Value$23.35 per share Price / Book1.29Miscellaneous Outstanding Shares126,500,000Free Float123,210,000Market Cap$3.80 billion OptionableOptionable Beta2.73 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Wayne Scott DeVeydt (Age 53)Exec. Chairman Comp: $250kMr. J. Eric Evans (Age 46)CEO & Director Comp: $1.45MMr. David T. Doherty (Age 51)Exec. VP & CFO Comp: $1.03MMs. Jennifer B. Baldock (Age 52)Exec. VP and Chief Admin. & Devel. Officer Comp: $1.05MMr. Bradley R. Owens (Age 53)Pres of National Group Comp: $684.02kMr. Harrison R. Bane (Age 36)Pres of American Group Comp: $428.77kMr. Varun GadhokSr. VP & Chief Information OfficerMs. Roxanne WomackSr. VP & Chief Compliance OfficerMs. Danielle Burkhalter (Age 38)Sr. VP & Chief HR Officer Mr. Anthony W. Taparo (Age 57)Chief Growth Officer More ExecutivesKey CompetitorsPediatrix Medical GroupNYSE:MDInari MedicalNASDAQ:NARIGinkgo BioworksNYSE:DNAInsmedNASDAQ:INSMImmunoGenNASDAQ:IMGNView All CompetitorsInsiders & InstitutionsBarclays PLCBought 43,035 shares on 9/21/2023Ownership: 0.075%Harrison R BaneSold 3,835 sharesTotal: $137,983.30 ($35.98/share)David T DohertySold 202 sharesTotal: $7,112.42 ($35.21/share)Alberta Investment Management CorpBought 45,388 shares on 8/24/2023Ownership: 0.036%Stonebridge Capital Advisors LLCBought 1,000 shares on 8/23/2023Ownership: 0.001%View All Insider TransactionsView All Institutional Transactions SGRY Stock - Frequently Asked Questions Should I buy or sell Surgery Partners stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SGRY shares. View SGRY analyst ratings or view top-rated stocks. What is Surgery Partners' stock price forecast for 2023? 9 equities research analysts have issued 1 year target prices for Surgery Partners' stock. Their SGRY share price forecasts range from $35.00 to $51.00. On average, they predict the company's stock price to reach $44.09 in the next twelve months. This suggests a possible upside of 46.8% from the stock's current price. View analysts price targets for SGRY or view top-rated stocks among Wall Street analysts. How have SGRY shares performed in 2023? Surgery Partners' stock was trading at $27.86 at the beginning of the year. Since then, SGRY stock has increased by 7.8% and is now trading at $30.03. View the best growth stocks for 2023 here. When is Surgery Partners' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023. View our SGRY earnings forecast. How were Surgery Partners' earnings last quarter? Surgery Partners, Inc. (NASDAQ:SGRY) issued its quarterly earnings data on Tuesday, August, 1st. The company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.03 by $0.22. The firm had revenue of $667.60 million for the quarter, compared to the consensus estimate of $667.94 million. Surgery Partners had a negative net margin of 2.04% and a positive trailing twelve-month return on equity of 1.95%. What ETFs hold Surgery Partners' stock? ETFs with the largest weight of Surgery Partners (NASDAQ:SGRY) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS) and BlackRock Future Innovators ETF (BFTR).iShares U.S. Healthcare Providers ETF (IHF). What guidance has Surgery Partners issued on next quarter's earnings? Surgery Partners issued an update on its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.75B-, compared to the consensus revenue estimate of $2.78 billion. What is Eric Evans' approval rating as Surgery Partners' CEO? 7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees. What other stocks do shareholders of Surgery Partners own? Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Sorrento Therapeutics (SRNE), Rigel Pharmaceuticals (RIGL), Ardelyx (ARDX), Glu Mobile (GLUU), Ocular Therapeutix (OCUL), Sangamo Therapeutics (SGMO), Xilinx (XLNX), Allena Pharmaceuticals (ALNA), Editas Medicine (EDIT) and Maxar Technologies (MAXR). What is Surgery Partners' stock symbol? Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY." Who are Surgery Partners' major shareholders? Surgery Partners' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Durable Capital Partners LP (4.25%), BlackRock Inc. (4.25%), Clearbridge Investments LLC (4.14%), Point72 Asset Management L.P. (1.28%), State Street Corp (1.16%) and Dimensional Fund Advisors LP (1.13%). Insiders that own company stock include Anthony Taparo, Bradley R Owens, Brent Turner, Danielle Burkhalter, David T Doherty, George Goodwin, Harrison R Bane, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Marissa Brittenham, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt. View institutional ownership trends. How do I buy shares of Surgery Partners? Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Surgery Partners' stock price today? One share of SGRY stock can currently be purchased for approximately $30.03. How much money does Surgery Partners make? Surgery Partners (NASDAQ:SGRY) has a market capitalization of $3.80 billion and generates $2.54 billion in revenue each year. The company earns $-54,600,000.00 in net income (profit) each year or ($0.56) on an earnings per share basis. How many employees does Surgery Partners have? The company employs 12,200 workers across the globe. How can I contact Surgery Partners? Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The official website for the company is www.surgerypartners.com. The company can be reached via phone at (615) 234-5900, via email at ir@surgerypartners.com, or via fax at 615-234-5998. This page (NASDAQ:SGRY) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surgery Partners, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.